40 Participants Needed

Brain Structure Assessment for Juvenile-onset Huntington's Disease

Recruiting at 5 trial locations
SS
SS
Overseen BySonia Slevinski, MS
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: University of Iowa
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to understand how brain development in young people with Juvenile-onset Huntington's Disease (JoHD) differs from those with the adult form of the disease. Researchers seek to identify specific brain changes that can serve as reliable markers for JoHD. Participants will undergo tests and scans to gather this information. Individuals diagnosed with JoHD, aged 6 to 30, and without other major health issues might be suitable for this study. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that may lead to better understanding and future treatments for JoHD.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Why are researchers excited about this trial?

Researchers are excited about this trial because it's diving deep into understanding how juvenile-onset Huntington's disease affects the brain over time. Unlike existing treatments that primarily aim to manage symptoms, this observational study focuses on mapping changes in brain structure and function. By pinpointing these changes, scientists hope to uncover new insights that could lead to more effective interventions in the future. This approach is groundbreaking because it shifts the focus from symptom management to understanding the disease's progression at a fundamental level.

Who Is on the Research Team?

PC

Peggy C Nopoulos, MD

Principal Investigator

University of Iowa

Are You a Good Fit for This Trial?

Inclusion Criteria

Clinical diagnosis of JoHD
Aged 6-30

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Participants undergo initial cognitive tests, behavioral assessments, physical and neurologic evaluation, and MRI

1 day
1 visit (in-person, 7-8 hours)

Longitudinal Assessment

Participants are assessed for brain structure and function using MRI, cognitive tests, and behavioral assessments

Ongoing
Multiple visits (in-person, 7-8 hours each)

Follow-up

Participants are monitored for changes in brain structure and function over time

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Observational Study

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Iowa

Lead Sponsor

Trials
486
Recruited
934,000+

The University of Texas Health Science Center, Houston

Collaborator

Trials
974
Recruited
361,000+

Children's Hospital of Philadelphia

Collaborator

Trials
749
Recruited
11,400,000+

UCL Queen Square Institute of Neurology

Collaborator

Trials
2
Recruited
80+

George-Huntington-Institut GmbH

Collaborator

Trials
2
Recruited
80+

Columbia University

Collaborator

Trials
1,529
Recruited
2,832,000+

University of California, Davis

Collaborator

Trials
958
Recruited
4,816,000+